Barclays Keeps Their Buy Rating on Progyny (PGNY)
TipRanksApr 26 04:50 ET
Progyny Analyst Ratings
BenzingaApr 17 13:21 ET
Analysts Offer Insights on Healthcare Companies: Edgewise Therapeutics (EWTX) and Progyny (PGNY)
TipRanksApr 17 07:41 ET
Truist Financial Sticks to Its Buy Rating for Progyny (PGNY)
TipRanksApr 2 07:25 ET
Truist Financial Reaffirms Their Buy Rating on Progyny (PGNY)
TipRanksMar 14 07:25 ET
Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD), Progyny (PGNY) and Protagonist Therapeutics (PTGX)
TipRanksFeb 28 08:40 ET
Buy Rating Affirmed for Progyny Despite Seasonal Dip: Long-term Growth and Solid Fundamentals Justify Premium Valuation
TipRanksFeb 28 07:37 ET
Progyny: A Positive Growth Outlook Justifies Buy Rating Despite Q4 Miss
TipRanksFeb 28 06:37 ET
Progyny Analyst Ratings
BenzingaFeb 28 05:08 ET
Progyny (PGNY) Receives a Buy From Barclays
TipRanksFeb 28 03:36 ET
Progyny Analyst Ratings
BenzingaFeb 26 09:13 ET
Progyny (PGNY) Receives a Buy From Truist Financial
TipRanksFeb 26 07:16 ET
Truist Financial Keeps Their Buy Rating on Progyny (PGNY)
TipRanksJan 7 21:25 ET
BTIG Reaffirms Their Buy Rating on Progyny (PGNY)
TipRanksDec 31, 2023 05:18 ET
Analysts Offer Insights on Healthcare Companies: Annexon Biosciences (ANNX), Medtronic (MDT) and Progyny (PGNY)
TipRanksDec 21, 2023 07:10 ET
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Progyny (PGNY) and IQVIA Holdings (IQV)
TipRanksDec 1, 2023 08:30 ET
Progyny Analyst Ratings
BenzingaNov 8, 2023 07:43 ET
Progyny's Strong Growth and Momentum: An Optimistic Buy Rating Despite Macro Challenges and Price Adjustment
TipRanksNov 8, 2023 06:06 ET
Analysts Offer Insights on Healthcare Companies: Progyny (PGNY), DaVita (DVA) and Demant (OtherWILLF)
TipRanksNov 8, 2023 03:40 ET
Progyny's Robust Performance and Strong Market Demand Drive Buy Rating: An Analysis of Q3 2023
TipRanksNov 8, 2023 01:09 ET
No Data
No Data